Literature DB >> 27863217

Eukaryotic Ribosome as a Target for Cardiovascular Disease.

Simone Pellegrino1, Gulnara Yusupova2.   

Abstract

Cardiovascular diseases have been associated with genetic variants and increased plasma level of the secreted protein PCSK9. In this issue of Cell Chemical Biology, Petersen et al. (2016) describe an inhibitor of PCSK9 secretion in human cells that, surprisingly, targets the 80S ribosome.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27863217     DOI: 10.1016/j.chembiol.2016.11.004

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   8.116


  4 in total

1.  Digital Gene Expression Profiling Analysis of Aged Mice under Moxibustion Treatment.

Authors:  Nan Liu; Yunyao Jiang; Min Xing; Baixiao Zhao; Jincai Hou; Minyee Lim; Jian Huang; Xue Luo; Li Han
Journal:  Evid Based Complement Alternat Med       Date:  2018-05-02       Impact factor: 2.629

2.  Immunological analysis and differential genes screening of venous thromboembolism.

Authors:  Li-Na Gao; Qiang Li; Jian-Qin Xie; Wan-Xia Yang; Chong-Ge You
Journal:  Hereditas       Date:  2021-01-02       Impact factor: 3.271

Review 3.  Eukaryotic ribosome quality control system: a potential therapeutic target for human diseases.

Authors:  Peng-Yue Zhao; Ren-Qi Yao; Zi-Cheng Zhang; Sheng-Yu Zhu; Yu-Xuan Li; Chao Ren; Xiao-Hui Du; Yong-Ming Yao
Journal:  Int J Biol Sci       Date:  2022-03-14       Impact factor: 6.580

4.  The Identification and Validation of Hub Genes Associated with Acute Myocardial Infarction Using Weighted Gene Co-Expression Network Analysis.

Authors:  Junqiang Xue; Lu Chen; Hao Cheng; Xiaoyue Song; Yuekai Shi; Linnan Li; Rende Xu; Qing Qin; Jianying Ma; Junbo Ge
Journal:  J Cardiovasc Dev Dis       Date:  2022-01-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.